News and Trends 20 Dec 2022
Watch: SwedenBIO leading the way
SwedenBIO is the national non-profit association for the life science industry in Sweden, with more than 300 members.
Denmark
- Latest Posts
News and Trends 15 Dec 2022
MinervaX raises €72M to develop Group B Streptococcus vaccine
MinervaX ApS, a privately held Danish biotech company developing a novel vaccine against Group B Streptococcus (GBS), has completed a €72 million ($76.5 million) financing round. The equity financing of €22 million ($23.4 million) was co-led by new investors Trill Impact Ventures and Pureos Bioventures and includes existing investors REPAIR Impact Fund (Novo Holdings), Sunstone […]
News and Trends 14 Dec 2022
NMD Pharma cleared for spinal muscular atrophy trial
NMD Pharma A/S has received clearance for its investigational new drug (IND) application from the US Food and Drug Administration (FDA) to advance NMD670 into a phase II clinical study in patients of spinal muscular atrophy (SMA) type 3. NMD Pharma is a Danish clinical stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for […]
More News! 23 Nov 2022
Novo Nordisk announces $750M facility expansion
Novo Nordisk has announced plans to invest DKK 5.4 bn ($750m) in the expansion of existing facilities in Bagsværd, Denmark. The plans also include the construction of a new plant located in extension of the existing facilities. The investment will establish additional capacity in R&D for manufacturing of active pharmaceutical ingredients (API) to supply global […]
More News! 10 Nov 2022
Novo Nordisk supports Plant2Food platform with €27M funding
Novo Nordisk Foundation will support new open collaborative platform, Plant2Food, to accelerate the development of plant-based foods with up to €27 million ($26.9m) over the next five years. The platform, Plant2Food, will include researchers and companies collaborating and exploring complex challenges within plant and food science and sharing new knowledge across sectors – without taking […]
More News! 31 Oct 2022
Drug discovery company signs exclusive license to use university’s technology
A drug discovery and development company using deubiquitylase (DUB) modulators as therapeutics for areas of high unmet needs has signed an exclusive license with the University of Southern Denmark for its UbiSite technology. Sheelagh Frame, is chief scientific officer, at Ubiquigent, the company that has signed the agreement. She said: “We are delighted to have […]
ADVERTISEMENT
ADVERTISEMENT
News and Trends 31 Oct 2022
Scientists say RNA production inhibitors important in cancer research
A study by researchers at the Biomedical Institute of Seville (IBIS) and the University of Seville, in collaboration with the Danish Cancer Society, shows that inhibiting RNA synthesis after radiation therapy facilitates the death of tumor cells. The study was published in the journal Nature Communications. RNA has been shown to be essential for repairing […]
News and Trends 21 Oct 2022
Watch: NLS Days NLSInvest award winners – MyoPax
The two biotech start-up companies MyoPax and Asgards Therapeutics won first and second prize at NLSINvest Awards, out of 40 companies that participated in Nordic Life Science Days’ start-up pitching challenge. 40 selected Nordic start-up companies attended Nordic Life Science Days, the largest partnering conference for life sciences in the Nordics, in Malmö. As part […]
News and Trends 17 Oct 2022
Clinical Microbiomics acquires MS-Omics
Clinical Microbiomics, a microbiome research company, has acquired MS-Omics, a metabolomics provider based in Denmark. Clinical Microbiomics works on clonal-level microbiome profiling. With the acquisition, Clinical Microbiomics adds expertise in metabolite profiling from MS-Omics to further advance its systems biology platform and help researchers worldwide understand the microbiome and how to impact health and disease. […]
News and Trends 14 Oct 2022
Danish researchers create ‘Wikipedia of resistant bacteria’
According to the WHO, antibiotic resistance is one of the biggest threats to public health. Researchers at DTU in Denmark have created a new tool in the fight against resistant bacteria that, based on 214,000 microbiome samples, can create an overview of the problem across countries, people and environments. In the future, even a small […]
News and Trends 11 Oct 2022
Muna Therapeutics gets $4.9M grant for Parkinson’s disease research
Muna Therapeutics has been awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The grant will be used to support ongoing preclinical research and development of novel, brain-exposed, small molecule potassium channel type 1.3 (Kv1.3) blockers to abrogate neuroinflammation driven by disease-associated microglia and enhance neuroprotection as a disease-modifying […]
News and Trends 11 Oct 2022
Positive results from NMD Pharma myasthenia gravis trial
NMD Pharma A/S has reported positive top-line results from its phase I/IIa clinical trial of NMD670, recently granted orphan drug designation by the FDA for treatment of myasthenia gravis (MG). NMD670 was safe and well tolerated in healthy volunteers and patients. Administration of single doses of NMD670 was associated with clinically significant improvements in the […]
ADVERTISEMENT